Skip to Main Content

Paper Details

Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
Hum Pathol
29
2021
COVID-19, COVID-19 infections, Coronavirus disease 2019, ISH, SARS, SARS-, SARS-CoV-2, SARS-CoV-2 viral RNA, Vero E6, Vero E6 positive cell line, control cell line, organ failure, patients, severe acute respiratory syndrome coronavirus, spike protein mRNA, tissue
Author NameAffiliation
Nadejda M TsankovaThe Icahn School of Medicine at Mount Sinai Hospital
Lisa MiorinThe Icahn School of Medicine at Mount Sinai Hospital, USA Global Health and Emerging Pathogens Institute
Teresa AydilloThe Icahn School of Medicine at Mount Sinai Hospital, USA Global Health and Emerging Pathogens Institute
Michael SchotsaertThe Icahn School of Medicine at Mount Sinai Hospital, USA Global Health and Emerging Pathogens Institute
Randy A AlbrechtThe Icahn School of Medicine at Mount Sinai Hospital, USA Global Health and Emerging Pathogens Institute
Nancy FrancoeurThe Icahn School of Medicine at Mount Sinai Hospital
Robert SebraThe Icahn School of Medicine at Mount Sinai Hospital
Robert SebraThe Icahn School of Medicine at Mount Sinai Hospital
Stuart C SealfonThe Icahn School of Medicine at Mount Sinai Hospital
Adolfo Garc??a-SastreThe Icahn School of Medicine at Mount Sinai Hospital, USA Global Health and Emerging Pathogens Institute, USA The Tisch Cancer Institute
William H WestraThe Icahn School of Medicine at Mount Sinai Hospital
  • 1 - 11

Datasets

Release 1.2